Davis's Drug Guide
suzetrigine
General
Pronunciation:
soo-se-tri-jeen
Trade Name(s)
- Journavx
Ther. Class.
Pharm. Class.
sodium channel blockers
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Suzetrigine." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580142/all/suzetrigine.
Vallerand AHA, Sanoski CAC, . Suzetrigine. Davis's Drug Guide. F.A. Davis Company; 2025. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580142/all/suzetrigine. Accessed October 19, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Suzetrigine. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580142/all/suzetrigine
Vallerand AHA, Sanoski CAC, . Suzetrigine [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 19]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580142/all/suzetrigine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - suzetrigine
ID - 3580142
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/3580142/all/suzetrigine
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -
